She owns a bunch of shares as well...
Monica Iancu, MIND CTI CEO, commented: "Focused on offering the best products and services at the lowest cost, in order to better serve our customers and build a competitive advantage, we implemented across the company, for the last two years, processes designed to improve our operating efficiency and productivity. With these processes in place we believe that the existing workforce is at the size we need in order to reach our goals. In parallel, we invested in developing the next versions of our platforms and we will continue to invest in expanding our offering. The new deal we closed at the beginning of the quarter and the multiple follow-on orders give us better visibility into 2017."
Recent MNDO News
- MIND CTI Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 03/06/2024 12:09:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2024 11:25:39 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:23:13 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/29/2024 06:42:40 PM
- MIND CTI Reports Third Quarter 2023 Results • GlobeNewswire Inc. • 11/08/2023 11:43:14 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/08/2023 11:04:02 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 09/29/2023 04:37:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2023 10:19:30 AM
- MIND CTI Reports Second Quarter 2023 Results • GlobeNewswire Inc. • 08/08/2023 10:32:06 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/08/2023 10:03:56 AM
- MIND CTI Reports First Quarter 2023 Results • GlobeNewswire Inc. • 05/10/2023 12:23:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM